Connection
Diana Medgyesy to Infusions, Intravenous
This is a "connection" page, showing publications Diana Medgyesy has written about Infusions, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.008 |
|
|
|
-
Pazdur R, Medgyesy DC, Winn RJ, Dakhil SR, Moore DF, Scalzo A, Hoff PM, Arbuck SG, Abbruzzese JL. Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Invest New Drugs. 1998-1999; 16(4):341-6.
Score: 0.008